EGFR and cancer: The majority of these pathways are vital for cancer progression, including “Endometrial cancer”, “Renal cell carcinoma”, “ErbB signaling pathway”, “Colorectal cancer”, “Thyroid cancer”, “Thyroid cancer” (Fig. 2E).